Cover Image

Administered Prices. hearings before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Sixth Congress, second session, on May 10-13, 1960. Part 21, Administered Prices in the Drug Industry (General: Generic and Brand Names) :

Focuses on problems related to use of generics in place of brand name drugs.

Bibliographic Details
Corporate Authors:	United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O., 1960.
Series:	U.S. Congressional Hearings.
Subjects:	Drugs > United States > Generic substitution. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

Frecuentes preguntas acerca de las drogas genéricas.
Published: (2004)

The marketing of generic drugs : a guide to counter-strategies for the technology intensive pharmaceutical companies /
by: James, Barrie G.
Published: (1981)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

Generic drugs : saving money at the pharmacy.
Published: (1998)

Prescription drugs : implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives /
by: Jagger, Sarah F.
Published: (1996)

Competition in the drug industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, first session, March 10, 1981.
Published: (1981)

Generic substitution and prescription drug prices : economic effects of state drug product selection laws /
by: Masson, Alison, et al.
Published: (1985)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Authorized generic drugs : short-term effects and long-term impact.
Published: (2011)

Guidance for industry : alternate source of the active pharmaceutical ingredient in pending ANDAs.
Published: (2000)

Competitive problems in the pharmaceutical drug industry : hearing before the Subcommittee on Antitrust, Monopolas printed], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987.
Published: (1989)

FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)

Quick tips, when getting a prescription.
Published: (2002)

Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991.
Published: (1991)

Generic drug laws : a decade of trial, a prescription for progress /
Published: (1986)

Generic drugs : saving money at the pharmacy /
Published: (1998)

Legislative and regulatory responses to the FTC study on barriers to entry in the pharmaceutical marketplace : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, June 17, 2003.
Published: (2003)

Legislative and regulatory responses to the FTC study on barriers to entry in the pharmaceutical marketplace : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, June 17, 2003.
Published: (2003)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.
Published: (2018)

Generic Animal Drug and Patent Term Restoration Act : hearing before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, second session on H.R. 4982 ... September 14, 1988.
Published: (1989)

Drug pricing : poor prescription for consumers and taxpayers? : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Third Congress, second session, July 27, 1994.
Published: (1995)

Risk evaluation and mitigation strategies (REMS) and generic drugs /
by: Dabrowska, Agata
Published: (2018)

Generic drug product development : solid oral dosage forms /
Published: (2005)

Orange Book Transparency Act of 2019 : report (to accompany H.R. 1503) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Competition in the pharmaceutical industry : the declining profitability of drug innovation /
by: Statman, Meir
Published: (1983)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)

Hechos sobre los medicamentos genéricos.
Published: (2006)

Facts about generic drugs.
Published: (2006)

Examining the root causes of drug shortages : challenges in pharmaceutical drug supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, May 11, 2023.
Published: (2024)

Generic drug product development : bioequivalence issues /
Published: (2008)

Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.
Published: (2017)

Drug pricing : research on savings from generic drug use /
by: Dicken, John E.
Published: (2012)

Generic drugs : stakeholders views on improving FDA's information on patents : report to congressional committees /
Published: (2023)

Patent listing in FDA's Orange Book /
by: Hickey, Kevin J.
Published: (2024)

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 : report (to accompany H.R. 5668) (including cost estimate of the Congressional Budget Office).
Published: (2020)

Mosby's drugconsult.
Published: (2002)

Expanding the use of generic drugs.
Published: (2010)

Entry threats and pricing in the generic drug industry /
by: Wendling, Brett
Published: (2010)

Retrosynthesis in the manufacture of generic drugs : selected case studies /
by: Santos, Pedro Paulo, et al.
Published: (2021)